The p70(S6K) signalling pathway: A novel signalling system involved in growth regulation

Cancer Surveys

Volumn 27, Issue , 1996, Pages 271-292

  Grammer, T C ^a   Cheatham, L ^a   Chou, M M ^a   Blenis, J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE; INSULIN RECEPTOR; INTERLEUKIN 2 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; RAPAMYCIN; RIBOSOME PROTEIN; PROTEIN SERINE THREONINE KINASE; S6 KINASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVE SITE; GROWTH REGULATION; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL DIVISION; HUMAN; PHYSIOLOGY;

ANIMALS; CELL DIVISION; HUMANS; PROTEIN-SERINE-THREONINE KINASES; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION;

EID: 0029658805     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Arcaro A and Wymann MP (1993) Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3 4 5-trisphosphate in neutrophil responses. Biochemistry Journal 296 297-301
2. Ballou LM, Siegmann M and Thomas G (1988) S6 kinase in quiescent Swiss mouse 3T3 cells is activated by phosphorylation in response to serum treatment. Proceedings of the National Academy of Sciences of the USA 85 7154-7158
3. Ballou LM, Luther H and Thomas G (1991) MAP2 kinase and 70 S6 kinase lie on distinct signalling pathways. Nature 349 348-350
4. Bellacosa A, Testa JR, Staal SP and Tsichlis PN (1991) A retroviral oncogene, akt, encoding for a serine-threonine kinase containing an SH2-like region. Science 254 274-277
5. Berra E, Diaz-Meco MT, Lozano J et al (1995) Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. EMBO Journal 14 6157-6163
6. Blenis J and Erikson RL (1985) Regulation of a ribosomal protein S6 kinase activity by the Rous sarcoma virus transforming protein, serum, or phorbol ester. Proceedings of the National Academy of Sciences of the USA 82 7621-7625
7. v-src or by serum: dissociation from phorbol ester-mediated activity. Proceedings of the National Academy of Sciences of the USA 82 1733-1737
8. Blenis J, Spivack JG and Erikson RL (1984) Phorbol ester, serum, and Rous sarcoma virus transforming gene product induce similar phosphorylations of ribosomal protein S6. Proceedings of the National Academy of Sciences of the USA 81 6408-6412
9. Brown EJ, Albers MW, Shin TB et al (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369 756-758
10. Brown EJ, Beal PA, Keith CT et al (1995) Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature 377 441-446
11. Burgering BMT and Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 599-602
12. Cafferkey R, Young PR, McLaughlin MM et al (1993) Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Molecular and Cellular Biology 13 6012-6023
13. Calvo V, Crews CM, Vik TA and Bierer BE (1992) Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proceedings of the National Academy of Sciences of the USA 89 426-429
14. Cardenas ME and Heitman J (1995) FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity. EMBO Journal 14 5892-5907
15. Cheatham B, Vlahos CJ, Cheatham L et al (1994) Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Molecular and Cellular Biology 14 4902-4911
16. S6k. Proceedings of the National Academy of Sciences of the USA 92 11696-11700
17. rsk phosphorylation and S6 phosphotransferase activity in swiss 3T3 cells by growth factor-, phorbol ester-, and cyclic AMP-mediated signal transduction. Molecular and Cellular Biology 11 1861-1867
18. Chen Y, Chen H, Rhoad AE et al (1994) A putative sirolimus (rapamycin) effector protein. Biochemical and Biophysical Research Communications 203 1-7
19. Chiu MI, Katz H and Berlin V (1994) RAPT1, a mammalian homolog of TOR, interacts with the FKBP12/rapamycin complex. Proceedings of the National Academy of Sciences of the USA 91 12574-12578
20. Chou MM and Blenis J (1995) The 70 kD S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Current Opinion in Cell Biology 7 806-814
21. Chung J, Kuo CJ, Crabtree GR and Blenis J (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signalling by the 70kD S6 protein kinases. Cell 69 1227-1236
22. s6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370 71-75
23. Coffer PJ and Woodgett JR (1991) Molecular cloning and characterization of a novel putative protein serine kinase related to the cAMP-dependent and protein kinase C families. European Journal of Biochemistry 201 475-481
24. Coffer PJ and Woodgett JR (1994) Differential subcellular localization of two isoforms of p70 S6 protein kinase. Biochemical and Biophysical Research Communications 198 780-786
25. s6 kinase. Molecular and Cellular Biology 16 2728-2735
26. de Groot RP, den Hertog J, Vandenheede JR, Goris J and Sassone-Corsi P (1993) Multiple and cooperative phosphorylation events regulate the CREM activator function. EMBO Journal 12 3903-3911
27. de Groot RP, Ballou LM and Sasssone-Corsi P (1994) Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell 79 81-91
28. Dhand R, Hiles I, Panayotou G et al (1994) PI 3-kinase is a specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO Journal 13 522-533
29. Dumont FJ, Altmeyer A, Kastner C et al (1994) Relationship between multiple biologic effects of rapamycin and the inhibition of pp70S6 protein kinase activity. Analysis in mutant clones of a T cell lymphoma. Journal of Immunology 152 992-1003
30. Dumont FJ, Staruch MJ, Grammer T et al (1995) Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. Journal of Immunology 163 70-79
31. Fantl WJ, Escobedo JA, Martin GA et al (1992) Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69 413-423
32. s6k. Critical Reviews in Biochemistry and Molecular Biology 29 385-413
33. Ferrari S, Bandi HR, Hofsteenge J, Bussian BM and Thomas G (1991) Mitogen-activated 70K S6 kinase. Journal of Biological Chemistry 266 22770-22775
34. s6k is associated with phosphorylation of four clustered sites displaying ser/thr motifs. Proceedings of the National Academy of Sciences of the USA 89 7282-7286
35. s6k through dephosphorylation of a novel set of sites. Journal of Biological Chemistry 268 16091-16094
36. Franco R and Rosenfeld MG (1990) Hormonally inducible phosphorylation of a nuclear pool of ribosomal protein S6. Journal of Biological Chemistry 265 4321-4325
37. Franke TF, Yang S, Chan TO et al (1995) The protein kinase encoded by the akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81 727-736
38. Graves LM, Bornfeldt KE, Argast GM et al (1995) cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proceedings of the National Academy of Sciences of the USA 92 7222-7226
39. s6k by inducing dephosphorylation of the same subset of sites. Journal of Biological Chemistry 270 21396-21403
40. Hanks SK, Quinn AM and Hunter T (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241 42-52
41. Hatakeyama M, Mori H, Doi T and Taniguchi T (1989) A restricted cytoplasmic region of the IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59 837-845
42. Heitman J, Mowa NR and Hall MN (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253 905-909
43. Heldin C-H and Westermark B (1984) Growth factors: mechanism of action and relation to oncogenes. Cell 37 9-20
44. Helliwell SB, Wagner P, Kunz J et al (1994) TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Molecular Biology of the Cell 5 105-118
45. Hershey JWB (1989) Protein phosphorylation controls translation rates. Journal of Biological Chemistry 264 20823-20826
46. Hiles ID, Otsu M, Volinia S et al (1992) Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70 419-429
47. Hu Q, Klippel A and Williams LT (1995) Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268 100-102
48. Jefferies HBJ, Reinhard C, Kozma SC and Thomas G (1994) Rapamycin selectively represses translation of the polypyrimidine tract mRNA family. Proceedings of the National Academy of Sciences of the USA 914441-4445
49. Kapeller R and Cantley LC (1994) Phosphatidylinositol 3-kinase. BioEssays 16 565-576
50. s6k containing a bifurcation to histone H3-HMG-like protein phosphorylation and c-fos-c-jun induction. Molecular and Cellular Biology 14 1066-1074
51. Krieg J, Hofsteenge J and Thomas G (1988) Identification of the 40 S ribosomal protein S6 phosphorylation sites induced by cycloheximide. Journal of Biological Chemistry 263 11473-11477
52. Kuo CJ, Chung J, Fiorentino DF et al (1992) Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358 70-73
53. Lam K, Carpenter CL, Ruderman NB, Friel JC and Kelly KL (1994) The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by wortmannin. Journal of Biological Chemistry 269 20648-20652
54. s6k function is essential for G1 progression. Nature 363 170-173
55. Lin T, Kong X, Haystead TAJ et al (1994) PHAS-1 as a link between mitogen-activated protein kinase and translation initiation. Science 266 653-656
56. Mahalingam M and Templeton DJ (1996) Constitutive activation of S6 kinase by deletion of amino-terminal autoinhibitory and rapamycin sensitivity domains. Molecular and Cellular Biology 16 405-413
57. Merida I, Williamson P, Kuziel WA, Greene WC and Gaulton GN (1993) The serine-rich domain of the interleukin-2 receptor β chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. Journal of Biological Chemistry 268 6765-6770
58. Mills GB, Stewart DJ, Mellors A and Gelfand EW (1986) Interleukin-2 does not induce phosphatidylinositol hydrolysis in activated T cells. Journal of Immunology 136 3019-3024
59. Mills GB, Girard P, Grinstein S and Gelfand EW (1988) Interleukin-2 induces proliferation of T lymphocyte mutants lacking protein kinase C. Cell 55 91-100
60. Minami Y, Kono T, Yamada K and Taniguchi T (1992) The interleukin-2 receptors: insights into a complex signalling mechanism. Biochimica et Biophysica Acta 1114 163-177
61. ras. Nature 371 426-429
62. Monfar M, Lemon KP, Grammer TC et al (1995) Activation of pp70/85-S6 kinases in IL-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Molecular and Cellular Biology 15 326-337
63. Morya S, Kazlauskas A, Akimoto K et al (1996) Platelet-derived growth factor activates protein kinase C-epsilon through redundant and independent signaling pathways involving phospholipase C-gamma or phosphatidylinositol 3-kinase. Proceedings of the National Academy of Sciences of the USA 93 151-155
64. Mukhopadhayay NK, Price DJ, Kyriakis JM et al (1992) An array of insulin-activated, proline directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. Journal of Biological Chemistry 267 3325-3335
65. Myers MGJ and White MF (1993) The new elements of insulin signalling: insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42 643-650
66. s6k signalling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. Journal of Biological Chemistry 269 28783-28789
67. Nakanishi H, Brewer KA and Exton JH (1993) Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5 trisphosphate. Journal of Biological Chemistry 268 13-16
68. Nielson FC, Ostergaard L, Nielson J and Christiansen J (1995) Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature 377 358-362
69. Nishimura R, Li W, Kashishian A et al (1993) Two signalling molecules share a phosphotyrosine-containing site in the platelet-derived growth factor receptor. Molecular and Cellular Biology 13 6889-6896
70. Nishizuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308 693-698
71. Nishizuka Y (1992) Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 607-614
72. Nourse J, Firpo E, Flanagan WM et al (1994) Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 570-573
73. Pause A, Belsham GJ, Gingras A et al (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′ -cap function. Nature 371 762-767
74. Pawson T (1995) Protein modules and signalling networks. Nature 373 573-580
75. Pearson RB, Dennis PB, Han J-W et al (1995) The principal target of rapamycin-induced p70S6K inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO Journal 14 5279-5287
76. Pelech SL and Krebs EG (1987) Mitogen-activating S6 kinase is stimulated via protein kinase C-dependent and independent pathways in Swiss 3T3 cells. Journal of Biological Chemistry 262 11598-11606
77. Polyak K, Lee MH, Erdjument-Bromage H et al (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 59-66
78. Price DJ, Mukhopadhyay NK and Avruch J (1991) Insulin-activated protein kinases phosphorylate a pseudosubstrate synthetic peptide inhibitor of the p70 S6 kinase. Journal of Biological Chemistry 266 16281-16284
79. Price DJ, Grove JR, Calvo V, Avruch J and Bierer BE (1992) Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257 973-977
80. s6k: functional requirement for entry into S phase. EMBO Journal 13 1557-1565
81. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P and Snyder SH (1994) RAFT-1: a mammalian protein that binds FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78 35-43
82. Sabatini DM, Pierchala BA, Barrow RK, Schell MJ and Snyder SH (1995) The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity. Journal of Biological Chemistry 270 20875-20878
83. Sabers CJ, Martin MM, Brunn GJ et al (1995) Isolation of a protein target of the FKBP-rapamycin complex in mammalian cells. Journal of Biological Chemistry 270 815-822
84. Schreiber SL (1991) Chemistry and biology of the immunophilins and their immunosuppressant ligands. Science 251 283-287
85. Stan R, McLaughlin MM, Cafferkey R et al (1994) Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue, Journal of Biological Chemistry 269 32027-32030
86. Susa M, Olivier AR, Fabbro D and Thomas G (1989) EGF induces biphasic S6 kinase activation: late phase is protein kinase C-dependent and contributes to mitogenicity. Cell 57 817-824
87. s6k activation induced by epidermal growth factor but not platelet-derived growth factor or insulin. Journal of Biological Chemistry 267 6905-6909
88. Takahashi JS (1993) Orcadian clocks a la CREM. Nature 365 299-300
89. Terada N, Lucas JJ, Szepesi A et al (1992) Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells. Biochemical and Biophysical Research Communications 186 1315-1321
90. 1 phase of the cycle. Journal of Cellular Physiology 254 7-15
91. Terada N, Patel HR, Takase K et al (1994) Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proceedings of the National Academy of Sciences of the USA 91 11477-11481
92. 3. Journal of Biological Chemistry 269 32358-32367
93. Trevillyan JM, Kulkarni RK and Byus CV (1984) Tumor-promoting phorbol esters stimulate the phosphorylation of ribosomal protein S6 in quiescent Reuber H35 hepatoma cells. Journal of Biological Chemistry 259 897-902
94. Valge VE, Wong JGP, Datlof BM, Sinskey AJ and Rao A (1988) Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell 55 101-112
95. Valius M and Kazlauskas A (1993) Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73 321-334
96. Vlahos CJ, Matter WF, Hui KY and Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholmyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Journal of Biological Chemistry 267 5241-5248
97. Wang LM, Myers MGJ, Sun XJ et al (1993) IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261 1591-1594
98. Weng Q, Andrabi K, Kozlowski MT, Grove JR and Avruch J (1995a) Multiple independent inputs are required for activation of the p70 S6 kinase. Molecular and Cellular Biology 15 2333-2340
99. Weng Q, Andrabi K, Klippel A et al (1995b) Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proceedings of the National Academy of Sciences of the USA 92 5744-5748
100. Yano H, Satoshi N, Kimura K et al (1993) Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol-3-kinase in RBL-2H3 cells. Journal of Biological Chemistry 268 25846-25856